Helix Biopharma Corp.Helix Biopharma Corp.Helix Biopharma Corp.

Helix Biopharma Corp.

No trades
See on Supercharts
Next report date
Report period
Q3 2024
EPS estimate
Revenue estimate
Market capitalization
‪30.83 M‬USD
−0.0211USD
‪−4.77 M‬USD
‪175.75 M‬
Beta (1Y)
0.96

About HELIX BIOPHARMA CORP

CEO
Jacek Antas
Headquarters
Toronto
Employees (FY)
7
Founded
1995
FIGI
BBG000K9PRS0
Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. It also funds research through issuance of common shares and warrants. The company was founded by Jerome F. McElroy on July 31, 1995 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HBPCF is 0.1377 USD — it has decreased by 6.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Helix Biopharma Corp. stocks are traded under the ticker HBPCF.
Helix Biopharma Corp. is going to release the next earnings report on Jun 11, 2024. Keep track of upcoming events with our Earnings Calendar.
HBPCF stock is 7.48% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is Helix Biopharma Corp. there?
Yes, you can track Helix Biopharma Corp. financials in yearly and quarterly reports right on TradingView.
HBPCF net income for the last quarter is ‪−903.53 K‬ USD, while the quarter before that showed ‪−1.63 M‬ USD of net income which accounts for 44.65% change. Track more Helix Biopharma Corp. financial stats to get the full picture.
Today Helix Biopharma Corp. has the market capitalization of ‪33.31 M‬, it has increased by 8.16% over the last week.
No, HBPCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HBPCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Helix Biopharma Corp. stock right from TradingView charts — choose your broker and connect to your account.
HBPCF reached its all-time high on Jan 26, 2011 with the price of 3.5600 USD, and its all-time low was 0.1377 USD and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is Helix Biopharma Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Helix Biopharma Corp. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Helix Biopharma Corp. stock shows the sell signal. See more of Helix Biopharma Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.